Hemopharm & Eratis merger
ERATIS & HEMOPHARM two French manufacturers and leaders in their respective markets merge to create HEMOPHARM / ERATIS
HEMOPHARM thanks to the confidence of its customers for the last 20 years placed as leader in the field of blood transfusion and blood collection.
ERATIS present itself as market leader in climate rooms for stable temperatures within the pharmaceutical industry, the health industry and in life sciences. ERATIS is right now one of the most outstanding companies in its market.
The merger of these two complementary entities, will fulfill the needs of our (GMIP, FDA, ICH, BPF activity STS, NFX15140) within their respective markets.
The development of the group HEMOPHARM/ERATIS will be based on three main areas:
- Development and manufacture of new products for the control of blood transfusion.
- Development of the sales service for all the products of the group.
- Reinforcement of the quality assurance service for the equipment validation
To celebrate this new born, the group’s activity takes a on a new dimension despite a difficult competitive environment, and maintains its leading position constantly improving the quality of its products and service through the proximity of their commercial and technical teams.
Contact:
HEMOPHARM +33 (0)5 63 22 05 40 www.hemopharm.fr
ERATIS +33 5 (0)62 79 01 22 www.eratis.com